EUCTR2007-005920-34-NL进行中（未招募）不适用
HD17 for Intermediate Stage Hodgkin Lymphoma - Treatment Optimization Trial in the First-Line Treatment of intermediate Stage Hodgkin lymhoma; Therapy stratification by means of FDG-PET - HD17
VU University Medical Center0 个研究点目标入组 1,100 人开始时间: 2012年8月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 1,100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Histologically proven Hodgkin lymphoma
- •Newly diagnosed, no previous treatment
- •Stage I, IIA with RF a-d; stage IIB with RF c, d
- •(a: large mediastinal mass, b: extranodal disease, c: high ESR, d: = 3 lymph node areas)
- •Age: 18-60 years
- •Patient had no previous treatment for HL
- •Normal organ function (except HL-related);
- •Life expectancy > 3 months.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Composite lymphoma
- •Previous malignancy, prior chemotherapy or radiotherapy
- •Concurrent diseases which preclude protocol treatment
- •Pregnancy, lactation
- •Non-compliance
- •WHO activity index > 2
- •Antiepileptic treatment
- •Concurrent diseases which preclude protocol treatment
- •Long-term administration of corticosteroids (e.g. for chronic polyarthritis) or antineoplastic drugs (e.g. azathioprine, methotrexate)
研究者
相似试验
进行中（未招募）
1 期
HD17 for Intermediate Stage Hodgkin Lymphoma - Treatment Optimization Trial in the First-Line Treatment of intermediate Stage Hodgkin lymhoma; Therapy stratification by means of FDG-PET - HD17Hodgkin Lymphoma intermediate stageMedDRA version: 20.0Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2007-005920-34-DEniversity of Cologne1,100
已完成
3 期
HD17 for Intermediate Stage Hodgkin Lymphoma - Treatment Optimization Trial in the First-Line Treatment of intermediate Stage Hodgkin lymhoma; Therapy stratification by means of FDG-PETHodgkin's Disease10025319malignant lymphomaNL-OMON47350Vrije Universiteit Medisch Centrum30
进行中（未招募）
1 期
HD18 for advanced stages in Hodgkins Lymphoma - HD18EUCTR2007-003187-22-CZniversity of Cologne2,101
进行中（未招募）
1 期
HD18 for advanced stages in Hodgkins LymphomaHodgkin´s lymphoma advanced stageEUCTR2007-003187-22-DEniversity of Cologne1,600
进行中（未招募）
1 期
HD16 for early stages in Hodgkins LymphomaHodgkin´s Lymphomaearly stageEUCTR2007-004474-24-DEniversity of Cologne1,150